NCT07572968 Dual-Task Effects on Gait and Balance in MCRS
| NCT ID | NCT07572968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Balikesir University |
| Condition | Motoric Cognitive Risk Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 35 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2026-04-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35 participants in total. It began in 2026-04-15 with a primary completion date of 2026-04-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effects of cognitive load on gait and balance performance in individuals with Motoric Cognitive Risk Syndrome (MCRS). Participants will perform Timed Up and Go (TUG) and tandem walking tests under single-task and dual-task conditions. The study evaluates cognitive-motor interference and dual-task cost to better understand early markers of cognitive decline and fall risk.
Eligibility Criteria
Inclusion Criteria: Age ≥ 65 years Subjective cognitive complaints Slow gait speed No dementia diagnosis Exclusion Criteria: Severe visual/hearing impairment Neurological diseases (stroke, Parkinson) Acute orthopedic conditions affecting walking
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07572968 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Motoric Cognitive Risk Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07572968 currently recruiting?
Yes, NCT07572968 is actively recruiting participants. Contact the research team at ebrutekin123@gmail.com for enrollment information.
Where is the NCT07572968 trial being conducted?
This trial is being conducted at Balıkesir, Turkey (Türkiye).
Who is sponsoring the NCT07572968 clinical trial?
NCT07572968 is sponsored by Balikesir University. The trial plans to enroll 35 participants.